Click here for more
Click here for more
Click here for more
 
Bladder Tumors
You are here: Urology>Diseases>Bladder Tumors


Anatomy
Diseases
  Bladder Tumors
  BPH
  Erectile Dysfunction (Impotence)
  Urothiliasis (Stones)
  Overactive Bladder
  Priapism
  Prostate Cancer
  Prostatitis
  Renal (Kidneys) Tumors
  Renal (Kidneys) Cyst
  Urinary Tract Infections
  Varicoceles
Procedures/Investigation
Photo Gallery

Bladder Tumours

Benign tumours of the bladder are rare; however, bladder cancer (malignant tumours) is the second most common genitourinary tract cancer after prostate cancer.

It is commoner in industrialised countries, more in Caucasian than blacks. It has a 3:1, male to female ratio with most patients being over 50years and the peak prevalence amongst the 60 to 70years old

Established risks factors include:

Tobacco/cigarette smoking.
Smoking appears to be the single greatest risk factor for bladder cancer. carcinogens in tobacco become concentrated in your urine causing damage the lining of your bladder which may cause transformation of the normal epithelium resulting in cancer. Smokers are at least twice as likely to develop bladder cancer that non-smokers. The risk is directly proportional to the number of sticks smoked a day and the number of years.

Chemotherapy and certain drugs.
Treatment with the anti-cancer drugs cyclophosphamide increases your risk of bladder cancer and phenacetin abuse predispose to bladder cancer.

Chronic bladder inflammation.
Chronic or repeated urinary infections or inflammations (cystitis), such as may happen in people with congenital abnormalities of the urinary tract ,prolonged use of a urinary catheter, or infestation with schistosomiasis (a parasitic infection)

Personal or family history.
Having bladder cancer once makes it more likely you'll get it again. Tumours may reoccur anywhere along the urinary tract as the same type of epithelial cells occur in your kidneys, ureters and urethra.

Most bladder cancers begin in the epithelial cells that line the walls of the bladder (transitional cells) and are confined to the bladder lining (carcinoma in situ). Others may invade the tissue below the epithelium(the surface of the inner lining) through the bladder wall, and from there into nearby structures e.g. prostate in men and uterus in women. distant spread to other organs occur eventually e.g. to the lungs, liver or bones

Types
Cancer originates in the epithelium, smooth muscle and fibrous layer. They may be transitional, squamous (common in Africa), anaplastic or adenocarcinoma.

Clinical Features

Bladder cancer does not usually manifest clinically with signs or symptoms in its early stages. however they include:

Haematuria: principal symptom. Usually painless, becoming painful with advance. It is usually the first warning sign.

Frequency: frequently passing urine. Usually occurs when infection supervenes.

Urinary retention: if urethra is blocked

Bone pain, weight loss, anaemia etc

Investigation
Urine cytology. A sample of your urine may be analyzed under a microscope to check for cancer cells.

Cystoscopy
Clinical Staging is based on;

(i) Urethrocystoscopy and a biopsy of the tumour.

(ii) Computerized tomography (CT),Magnetic resonance imaging (MRI), Intravenous Urography or Ultrasound scan to see an image of your kidneys and lower urinary tract, including your bladder. it may show evidence of hydronephrosis

(iii) Chest X-ray- This test may help detect cancer that has spread to your lungs. , radioisotope bone scan-used to determine whether cancer has spread to your bones, routine Liver function test.

Bladder cancer is staged using the numbers 0 to IV.

Stage 0 cancer. carcinoma in situ .occurs when the cancer is limited only to epithelium of the bladder. Complete removal of the cancer is achievable however recurrence rate is high.

Stage I cancer. Cancer at this stage occurs in the bladder's inner lining, but hasn't invaded the muscular bladder wall.

Stage II cancer. At this stage, cancer has invaded the bladder wall but has not reached the surrounding structures

Stage III cancer. The cancer cells have spread through the bladder wall to surrounding structures

Stage IV cancer. Distant spred to other organs e.g lungs, liver or bones.

Recurrent. This refers to cancer that has returned after having been treated. It may recur in the same place or in another part of your body.

Treatment
This depends on the type of cancer, the stage of the disease, the patient’s age and general health status.

Therapeutic options include surgery, chemotherapy, radiotherapy, immunotherapy or a combination of all modes.

Surgery:Surgical treatments are usually the best option for people with bladder cancer.

(i) partial: resection of that part of the bladder to which the tumour is limited.

(ii) radical: it is used for invasive bladder cancer or for superficial cancer that affects a large portion of the bladder. it involves total removal of the bladder and the nearby lymph nodes. In men the prostate may be removed as well; in women, a subtotal hysterosalphingectomy may be done as well.

Transurethral resection (TUR). Using a cystoscope, the cancer is removed with a small wire loop and any remaining cells are cauterized (burnt with an electric current).

Chemotherapy: special drugs that destroy cancer cells are administered orally, intravenously or directly into the bladder (intravesical)

Usually, two or more drugs are used in combination.

Radiotherapy: used as an adjunct before or after surgery with radioactive implants or external beam radiation. it is seldomly used alone as in when other clinical condition of the patient negates surgery.

Immunotherapy: used in low grade cancer.Bacille Calmette-Guerin (BCG) is introduced into the bladder through the urethra for two hours, once weekly, at least six times to stimulate the immune system to destroy cancer cells. It binds to your bladder, where it triggers a response that inhibits the formation and growth of tumors.It's usually used after TUR to help prevent superficial bladder cancer from recurring.

Follow-up

Bladder cancer has a high rate of recurrence. Following appropriate treatment of “curable” cancer, watch should be kept for reoccurrence.

Urine cytology and cystoscopy are provided every 3 months for the first 2years, then every 6 months for the next 2years.

I.V.U

Prognosis:

if untreated, few patients with invasive cancer of the bladder survive 3years.

Prognosis varies with type and stage of the tumour, being better in low grade than high



 
Terms and Conditions | Privacy Policy | Disclaimer
Copyright © 2007 St. Mary's Specialist Centre